Skip to main content
Menu
US

AlphaLISA Human IgG1 (Isotyping) Detection Kit, 500 Assay Points

The AlphaLISA® IgG1 Detection Kit is designed for the quantitative determination of human IgG1 in serum, buffered solution, or cell culture medium using a homogeneous (no wash steps, no separation steps) assay.

This kit is a replacement for AL307.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Feature Specification
Application Protein Quantification
Dynamic Range 4.29 - 1,000,000 ng/mL  
Limit of Detection 3.82 ng/mL  
Limit of Quantification 4.29 ng/mL  
Sample Volume 5 µL

The AlphaLISA® IgG1 Detection Kit is designed for the quantitative determination of human IgG1 in serum, buffered solution, or cell culture medium using a homogeneous (no wash steps, no separation steps) assay.

This kit is a replacement for AL307.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Product Variants
Unit Size: 100 Assay Points
Part #:
AL3171HV
List Price
USD 1,095.00
Unit Size: 500 Assay Points
Part #:
AL3171C
List Price
USD 2,299.00
Unit Size: 5,000 Assay Points
Part #:
AL3171F
List Price
USD 15,220.00

Overview

Immunoglobulin G1 (IgG1) belongs to the immunoglobulin antibody family and is the most abundant IgG subclass. IgG molecules are created and released by plasma B cells and represent an important mediated antibody response against viral pathogens by binding to soluble proteins and membrane protein antigens via variable domain and concomitantly activating effector mechanisms of the innate immune system. IgG1 can bind to C1q, causing complement-dependent cytotoxicity (CDC), and can bind to each of the different Fc receptors resulting in antibody-dependent cell-mediated cytotoxicity (ADCC). Increased IgG1 levels have been associated with inflammatory or autoimmune diseases that involve the central nervous system and IgG1 deficiencies are associated with a weakened immune system and increased susceptibility of infection.

Formats
  • Our 100 assay point kit allows you to run 100 wells in 96-well format, using a 100 µL reaction volume (10 µL of sample).
  • Our 500 assay point kit allows you to run 500 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).
  • Our 5,000 assay point kit allows you to run 5,000 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).
Features
  • No-wash steps, no separation steps
  • ELISA alternative technology
  • Sensitive detection
  • Broad sample compatibility
  • Small sample volume
  • Results in less than 3 hours
  • Half the time of an ELISA assay

AlphaLISA technology allows the detection of molecules of interest in a no-wash, highly sensitive, quantitative assay. In an AlphaLISA assay, a biotinylated anti-analyte antibody binds to the Streptavidin-coated Donor beads while another anti-analyte antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads causes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.

Specifications

Application
Protein Quantification
Automation Compatible
Yes
Brand
AlphaLISA
Detection Modality
Alpha
Dynamic Range
4.29 - 1,000,000 ng/mL  
Limit of Detection
3.82 ng/mL  
Limit of Quantification
4.29 ng/mL  
Product Group
Kit
Sample Volume
5 µL
Shipping Conditions
Shipped in Blue Ice
Target
IgG1
Target Class
Biologics
Target Species
Human
Technology
Alpha
Unit Size
500 Assay Points

Image gallery

Video gallery

Resources

Are you looking for resources, click on the resource type to explore further.

1-1 of 1 Resources
Whitepaper Icon
Whitepaper
Antibody-based therapeutic modalities in oncology

With over 200 different types of cancer, management relies on a variety of techniques such as chemotherapy, radiotherapy, and...

Scroll Icon